Eledoisin Related Peptide
Need Assistance?
  • US & Canada:
    +
  • UK: +

Eledoisin Related Peptide

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Eledoisin-Related Peptide, a substance P analogue, is a tachykinin receptor ligand.

Category
Peptide Inhibitors
Catalog number
BAT-010472
CAS number
2990-43-4
Molecular Formula
C34H58N8O6S
Molecular Weight
706.94
Eledoisin Related Peptide
IUPAC Name
(2S)-2,6-diamino-N-[(2S)-1-[[(2S,3S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]hexanamide
Synonyms
Eledoisin-Related Peptide; Eledoisin RP; H-Lys-Phe-Ile-Gly-Leu-Met-NH2; L-lysyl-L-phenylalanyl-L-isoleucyl-glycyl-L-leucyl-L-methioninamide; (S)-2,6-diamino-N-((5S,8S,14S,17S)-14-sec-butyl-5-carbamoyl-8-isobutyl-7,10,13,16-tetraoxo-18-phenyl-2-thia-6,9,12,15-tetraazaoctadecan-17-yl)hexanamide; Lpiglm
Appearance
White Lyophilized Powder
Purity
≥95%
Density
1.166±0.06 g/cm3 (Predicted)
Melting Point
244-245°C
Boiling Point
1083.4±65.0°C (Predicted)
Sequence
KFIGLM-NH2
Storage
Store at -20°C
Solubility
Soluble in Water
InChI
InChI=1S/C34H58N8O6S/c1-6-22(4)29(42-33(47)27(19-23-12-8-7-9-13-23)41-31(45)24(36)14-10-11-16-35)34(48)38-20-28(43)39-26(18-21(2)3)32(46)40-25(30(37)44)15-17-49-5/h7-9,12-13,21-22,24-27,29H,6,10-11,14-20,35-36H2,1-5H3,(H2,37,44)(H,38,48)(H,39,43)(H,40,46)(H,41,45)(H,42,47)/t22-,24-,25-,26-,27-,29-/m0/s1
InChI Key
UCWISUCKJRPWFZ-HFYXWKFHSA-N
Canonical SMILES
CCC(C)C(C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CCCCN)N
1.Hyperalgesia produced by intrathecal substance P and related peptides: desensitization and cross desensitization.
Moochhala SM;Sawynok J Br J Pharmacol. 1984 Jun;82(2):381-8.
The hyperalgesic effect of intrathecally administered substance P (SP), physalaemin, eledoisin and eledoisin-related peptide (ERP) was investigated in the rat tail flick test. Hyperalgesia produced by SP (2.5-15 micrograms, 1.9-11 nmol) was maximal 10-20 min after injection, lasted 30 min and was dose-related. The effect was mimicked by all of the peptides examined. The rank order of potency was physalaemin greater than SP greater than eledoisin greater than ERP. Desensitization to the hyperalgesic effect of SP was produced by three repeated intrathecal injections. Rats desensitized to SP no longer responded to physalaemin or ERP, indicating cross-desensitization. Phentolamine continued to produce hyperalgesia following such desensitization. The demonstration of a hyperalgesic effect for SP provides further support for a role for SP in nociceptive transmission. The receptor mediating this effect appears to be a SP-P subtype. Cross-desensitization between peptides suggests an action on the same receptor.
2.Substance P: ionic basis for depolarizing responses of mouse spinal cord neurons in cell culture.
Nowak LM;Macdonald RL J Neurosci. 1982 Aug;2(8):1119-28.
Intracellular recording methods were used to investigate the ionic basis for the postsynaptic actions of substance P (SP) on mouse spinal cord neurons grown in primary dissociated cell culture. SP and an analog, eledoisin-related peptide (ERP), were applied to single neurons by pressure ejection of peptide-containing solutions from blunt (2- to 10-micrometers) glass micropipettes. SP and ERP had similar excitatory actions, increasing spontaneous activity and depolarizing neurons by decreasing membrane conductance. Depolarizing responses were not inverted by intracellular injection of chloride ions, suggesting that SP responses did not result from decreased chloride conductance. SP and ERP responses were not abolished by extracellular tetraethylammonium ions (TEA+) but were reduced or eliminated by intracellular TEA+, suggesting that SP reduced a potassium conductance (gK). Finally, SP and ERP responses were larger when neurons were depolarized and smaller when the cells were hyperpolarized, and extrapolated reversal potentials for the peptide responses were 10 to 30 mV more negative than resting membrane potential. Thus, it was concluded that SP depolarized spinal cord neurons by decreasing a membrane potassium conductance.
3.The effect of calcium ions on the responses to motoneurons to substance P and eledoisin-related peptide in the toad and rat spinal cord.
Spence I;Mills M Neuroscience. 1984 Jun;12(2):629-35.
The effects of changes in the external calcium ion concentration [Ca2+]0 on segmental reflexes and the responses of motoneurons to bath applied agonists have been studied in the toad and rat spinal cords in vitro. Reducing [Ca2+]0 enhanced polysynaptic reflexes in the toad, with maximal discharges occurring at 0.3 mM. Monosynaptic reflexes in the rat were reduced by lowering [Ca2+]0. Responses of toad motoneurons to substance P and eledoisin-related peptide were enhanced by lowering [Ca2+]0, maximum responses occurring at 0.3 mM. Lowering [Ca2+]0 also enhanced responses to L-glutamate but the effect was smaller and less consistent. This effect of Ca2+ was abolished by the addition of tetrodotoxin to the bathing solution. Toad motoneuron responses to gamma-aminobutyrate and glycine were not affected by alterations in [Ca2+]0. Rat motoneuron responses to substance P and eledoisin-related peptide were also enhanced by reductions in [Ca2+]0 but the effect was more pronounced in younger (less than 5 days post partum) than older (5-10 days post partum) animals. These results are consistent with the idea that motoneuron responses to peptides in normal solutions result from activation of receptors on both motoneurons and interneurons: enhancement of the responses by lowering [Ca2+]0 results from the potentiation of the transynaptic component.
Online Inquiry
Verification code
Inquiry Basket